MINI FUTURE LONG - FAGRON Share Price

NC41B

NL0011916036

Real-time Euronext Paris 11:49:12 08/05/2024 BST
12.39 ^EUR	+1.32%

Current month	+1.56%
1 month	+12.88%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart FAGRON N.V.

Latest news about FAGRON N.V.

Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting	04-15	AQ
Fagron N : NV, - publiceert agenda jaarlijkse en buitengewone aandeelhoudersvergadering 2024	04-12	PU
Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting	04-12	GL
Transcript : Fagron NV, Q1 2024 Sales/ Trading Statement Call, Apr 11, 2024	04-11

More news

Quotes 5-day view

Date	Price	Change	Volume
08/05/24	12.39	+1.32%	25
07/05/24	12.23	+2.56%	57
06/05/24	11.93	-1.14%	40
03/05/24	12.06	-0.07%	48
02/05/24	12.07	+0.25%	60

Real-time Euronext Paris

Last update May 08, 2024 at 11:49 am

More quotes

Static data

Product type	Knock-Out mit Stop Loss
Buy / Sell	CALL
Underlying	FAGRON N.V.
Issuer	BNP Paribas
	NC41B
ISIN	NL0011916036
Date issued	11/08/2016
Strike	6.33 €
Maturity	Unlimited
Parity	1 : 1
Emission price	- €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	16.98 €
Lowest since issue	1.11 €
Spread	0.07 €
Spread %	0.56%

Company Profile

Fagron N.V. specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The group ensures the sale of pharmaceutical formulas and raw materials, provides third-party pharmaceutical compounding services to pharmacists and hospitals, etc.

Sector

More about the company

Ratings for Fagron N.V.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Fagron N.V.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

18.46 EUR

Average target price

21.7 EUR

Spread / Average Target

+17.55%

Consensus